
News & Insights


Insight at Biologics Episode 4
On this episode of Insight at Biologics, Senior Consultant Dr. Emily Noonan Place from Biologics Consulting chats with James Taylor about IND submissions. The fact is that the regulatory agency doesn't get a lot of time with your IND submission. How then does one make the most of that time?

Insight at Biologics Episode 3
How does one know if you may have all the correct information for making a drug or device submission? A gap analysis from experienced experts can actually save you time and money! David Pepperl explains more in this episode of Insight at Biologics.



Biocompatibility Nuances And Its Impact On Medical Devices
Biocompatibility can be challenging and frustrating when developing a medical device. Why do you have to spend time and money to do the same testing, if the materials used in your device have already been tested, approved, and put in medical devices on the market? Biocompatibility impacts the majority…